Press Releases

On August 19, 2024, Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma," 03692.HK) announced that the new drug application ("NDA") for a new indica...

A real-world study of GLP-1 receptor agonists (GLP-1RAs) for treating patients with diabetic kidney disease (DKD) was recently published in the intern...

On July 19, 2024, Hansoh Pharma's New Drug Application (NDA) for Ameile (almonertinib mesylate tablets), an independently-developed class 1 new drug, ...

The 2024 ADA Meeting was held in Orlando, USA, from June 21st to 24th, this year. Hansoh Pharma's HS-20094 (a novel Dual GIP and GLP-1 Receptor Agonis...

Reaching for the sky and striving to achieve its ambitions. Recently at the celebration of 2024 International Worker's Day and the commendatory ceremo...

Recently, the Chinese Journal of Nephrologyreleased the “Chinese Expert Consensus on Long-Acting Erythropoiesis-Stimulating Agents in the Treatment of...

The 115th Annual Meeting of the American Association for Cancer Research (AACR) was convened in San Diego from April 5 to 10. At this year's meeting, ...

On March 29, 2024, the ceremony for the launch of Hansoh Pharmaceutical Group's construction project for its global R&D headquarters was held in Pudon...